XML 58 R47.htm IDEA: XBRL DOCUMENT v3.20.2
Financial Statement Information Investments in Unconsolidated Subsidiaries (Details)
$ in Thousands
3 Months Ended 9 Months Ended
Dec. 01, 2016
USD ($)
Dec. 31, 2020
USD ($)
Sep. 30, 2020
USD ($)
Sep. 30, 2019
USD ($)
Mar. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Sep. 30, 2020
USD ($)
Sep. 30, 2019
USD ($)
Sep. 30, 2020
SEK (kr)
Dec. 31, 2019
USD ($)
Mar. 31, 2019
SEK (kr)
Schedule of Equity Method Investments [Line Items]                      
Proceeds from (Payments to) Noncontrolling Interests   $ 10,000   $ 19,000              
Impairment of Long-Lived Assets to be Disposed of       (4,000)       $ (45,000)      
Equity method investments     $ 147,536       $ 147,536     $ 139,243  
Payments to Acquire Equity Method Investments             6,917 6,894      
Equity in (losses) earnings of unconsolidated subsidiaries     (4,113) (4,232)     (1,980) 33,745      
Impairment of equity method investments             0 39,551      
Share Price of the Equity Method Investment | kr                 kr 93   kr 65
Derivative Asset, Noncurrent     0       0     3,443  
Mekonomen [Member]                      
Schedule of Equity Method Investments [Line Items]                      
Equity method investments     118,000       118,000        
Equity Method Investment, Ownership Percentage 26.50%                    
Payments to Acquire Equity Method Investments $ 181,000         $ 48,000          
Equity Method Investment, Difference Between Carrying Amount and Underlying Equity     6,000       6,000        
Impairment of equity method investments         $ 40,000            
Equity Method Investments, Fair Value Disclosure     151,000       151,000        
Mekonomen [Member]                      
Schedule of Equity Method Investments [Line Items]                      
Equity Method Investment, Ownership Percentage           26.60%          
Europe [Member]                      
Schedule of Equity Method Investments [Line Items]                      
Equity method investments     128,806       128,806     121,619  
Equity in (losses) earnings of unconsolidated subsidiaries     4,000 4,000     5,000 (35,000)      
Notes issued in connection with purchase of noncontrolling interest       14,000              
North America [Member]                      
Schedule of Equity Method Investments [Line Items]                      
Equity method investments     18,730       18,730     $ 17,624  
Equity in (losses) earnings of unconsolidated subsidiaries     $ 400 $ 400     $ (3,000) $ 1,000